Cite
HARVARD Citation
Roussel, M. et al. (2020). Health-related quality of life results from the IFM 2009 trial: treatment with lenalidomide, bortezomib, and dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma. Leukemia & lymphoma. 61 (6), pp. 1323-1333. [Online].